Literature DB >> 6403646

Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets.

R S Accolla.   

Abstract

Two monoclonal antibodies, D1-12 and BT 2.2, recognizing two distinct subsets of human Ia molecules, NG1 and NG2, respectively, present in all individuals irrespective of their HLA-DR phenotype, have been used to immunoselect cell variants from the lymphoblastoid cell line Raji. Results showed that, irrespective of the monoclonal antibody used for immunoselection, the cell variants analyzed in this study had lost the expression of both D1-12-and BT 2.2-specific antigenic determinants. Moreover, the expression of antigenic determinants specific for a third family of Ia molecules, the DC-1 subset, were also lost in the cell variants. In contrast, expression of HLA A, B, and C common structures, as recognized by the W6.32 monoclonal antibody, as well as expression of surface immunoglobulins, were not affected. Possible mechanisms inducing such a coordinate loss of expression of several families of human Ia molecules are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403646      PMCID: PMC2186959          DOI: 10.1084/jem.157.3.1053

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  Re-analysis of radiation-induced specific locus mutations in the mouse.

Authors:  S Abrahamson; S Wolff
Journal:  Nature       Date:  1976 Dec 23-30       Impact factor: 49.962

2.  Analysis of HLA-D region-associated molecules with monoclonal antibody.

Authors:  D J Charron; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

3.  Demonstration at the single-cell level of the existence of distinct clusters of epitopes in two predefined human Ia molecular subsets.

Authors:  R S Accolla; R P Sekaly; A P McDonald; G Corte; N Gross; S Carrel
Journal:  Eur J Immunol       Date:  1982-02       Impact factor: 5.532

4.  Subsets of human Ia-like molecules defined by monoclonal antibodies.

Authors:  S Carrel; R Tosi; N Gross; N Tanigaki; A L Carmagnola; R S Accolla
Journal:  Mol Immunol       Date:  1981-05       Impact factor: 4.407

5.  Identification of a trans-acting function regulation HLA-DR expression in a DR-negative B cell variant.

Authors:  P Gladstone; D Pious
Journal:  Somatic Cell Genet       Date:  1980-03

6.  Distinct forms of both alpha and beta subunits are present in the human Ia molecular pool.

Authors:  R S Accolla; N Gross; S Carrel; G Corte
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

7.  Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells.

Authors:  P Kavathas; F H Bach; R DeMars
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

8.  Structural polymorphism of human DR antigens.

Authors:  J Silver; S Ferrone
Journal:  Nature       Date:  1979-05-31       Impact factor: 49.962

9.  Monoclonal antibody identifies a new Ia-like (p29,34) polymorphic system linked to the HLA-D/DR region.

Authors:  L M Nadler; P Stashenko; R Hardy; K J Tomaselli; E J Yunis; S F Schlossman; J M Pesando
Journal:  Nature       Date:  1981-04-16       Impact factor: 49.962

10.  Translation and assembly of HLA-DR antigens in Xenopus oocytes injected with mRNA from a human B-cell line.

Authors:  E O Long; N Gross; C T Wake; J P Mach; S Carrel; R Accolla; B Mach
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  80 in total

1.  CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.

Authors:  K Masternak; A Muhlethaler-Mottet; J Villard; M Zufferey; V Steimle; W Reith
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

2.  Self-association of CIITA and its transactivation potential.

Authors:  T J Sisk; S Roys; C H Chang
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

3.  Microcin E492, a channel-forming bacteriocin from Klebsiella pneumoniae, induces apoptosis in some human cell lines.

Authors:  Claudio Hetz; María Rosa Bono; Luis Felipe Barros; Rosalba Lagos
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

4.  CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.

Authors:  S B Hake; K Masternak; C Kammerbauer; C Janzen; W Reith; V Steimle
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

5.  Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.

Authors:  A Janz; M Oezel; C Kurzeder; J Mautner; D Pich; M Kost; W Hammerschmidt; H J Delecluse
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins.

Authors:  M Dohlsten; P A Lando; G Hedlund; J Trowsdale; T Kalland
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

Review 7.  Interactions between immunogenic peptides and HLA-DR molecules.

Authors:  J B Rothbard; R Busch
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

Review 8.  Transcriptional regulation of HLA class-II genes.

Authors:  B M Peterlin; G Andersson; E Lötscher; S Tsang
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

9.  The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.

Authors:  J A Brown; E M Rogers; J M Boss
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971

10.  An N- and C-terminal truncated isoform of zinc finger X-linked duplicated C protein represses MHC class II transcription.

Authors:  Anastasiia Aleksandrova; Oleksandr Galkin; Rupa Koneni; Joseph D Fontes
Journal:  Mol Cell Biochem       Date:  2009-09-24       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.